Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 2,000 |
| Receivables | 0 | 0 | 20 |
| Other current assets | 0 | 0 | 40 |
| TOTAL | $0 | $0 | $2,060 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 550 |
| Other Non-Current Assets | 0 | 0 | 110 |
| TOTAL | $N/A | $N/A | $660 |
| Total Assets | $0 | $0 | $2,340 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 370 |
| Other current liabilities | 0 | 0 | 10 |
| TOTAL | $0 | $0 | $380 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 1,080 |
| TOTAL | $N/A | $N/A | $1,080 |
| Total Liabilities | $0 | $0 | $1,460 |
| Shareholders' Equity | |||
| Common Shares | 0 | 0 | 530 |
| Retained earnings | 0 | 0 | -51,630 |
| Other shareholders' equity | 0 | 0 | 51,970 |
| TOTAL | $0 | $0 | $870 |
| Total Liabilities And Equity | $0 | $0 | $2,330 |